ClinicaGen Bio, LLC
We will help you determine and establish whether remnant and/or prospective collections are feasible to provide the clinical specimens and the rich clinical data your study requires.
ClinicaGen Bio offers extensive guidance when integrating sample collection projects into existing clinical procedures, minimizing risks and bottlenecks, increasing the margins of your clinical workflow through increased efficiency.
ClinicaGen Bio uses a system involving dual certification of data associated with specimens for enhanced quality assurance.
Enhancing the sustainability of community-based clinics and non-profits by increasing margins for existing clinical and lab efforts while connecting them to our pipeline of bio-specimen studies intrigues new sites and incentivizes existing ones.
ClinicaGen Bio provides regulatory infrastructure with IRB-approved protocols and ICFs, according to US and X-US standards. We utilize master agreements with nimble POs or SOWs to allow rapid fulfillment of the most complex requests.
Inclusion of diverse populations for enhanced regulatory goal attainment is one of our specialties and the benefit of working with our clinician-led procurement network.
We partner with the industry to provide expert clinical analysis of each collection request to determine whether prospective collection or retrospective (remnant) collection is optimal for your study's needs.
ClinicaGen Bio develops its hand-selected medical practices to efficiently integrate biospecimen studies into their clinical workflow, granting us more reliable timelines and faster rates of accrual.